- Home
- PRA vs SPRY Comparison
PRA vs SPRY Comparison
Compare PRA & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRA | SPRY |
|---|---|---|
| Founded | 1976 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PRA | SPRY |
|---|---|---|
| Price | $24.50 | $8.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $25.00 | ★ $40.00 |
| AVG Volume (30 Days) | 572.3K | ★ 952.0K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $1,098,028,000.00 | $84,278,000.00 |
| Revenue This Year | N/A | $109.11 |
| Revenue Next Year | N/A | $91.00 |
| P/E Ratio | $24.78 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.30 | $6.66 |
| 52 Week High | $24.77 | $18.63 |
Technical Indicators
Market Signals| Indicator | PRA | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 51.25 | 31.56 |
| Support Level | $23.88 | $8.05 |
| Resistance Level | $24.64 | $10.44 |
| Average True Range (ATR) | 0.12 | 0.46 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 28.00 | 7.41 |
Price Performance
Historical ComparisonAbout PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.